The additive value of second opinion teleconsulting in the management of patients with challenging inflammatory, neoplastic skin diseases: a best practice model in dermatology?
BACKGROUND
Telemedicine is the practice of healthcare using interactive processes of communication to facilitate healthcare delivery, including diagnosis, consultation and treatment, as well as education and transfer of medical data. The aim of teledermatology, just as telemedicine, is to promote best practice procedures and to improve the consistency and competence of health care.


OBJECTIVE
To investigate the diagnostic additive value of second opinion teleconsulting in patients with challenging dermatoses, among dermatologists working in two different dermatology departments.


METHODS
Thirty-three cases of patients with challenging inflammatory and neoplastic skin diseases at the University of L'Aquila Department of Dermatology were sent for teleconsultation to the Department of Dermatology, Medical University of Graz, Austria.


METHODS
All cases were selected in the outpatient service in L'Aquila. After face-to-face consultation with a local colleague had been completed, images were sent using a store-and-forward (SAF)-based system (http://www.telederm.org) to Graz. Histopathological examination together with follow-up of the patient represents the diagnostic gold standard for this study.


RESULTS
Telediagnosis was correct in 26 of 33 (78.8%) cases. Sixteen of 33 cases (48.5%) had already been diagnosed face-to-face by at least one of the two dermatologists in L'Aquila. In 10 of 33 cases (30.3%), the correct diagnosis was made in teleconsultation only.


CONCLUSIONS
Second opinion teleconsulting may represent an additive value in the diagnosis of numerous challenging inflammatory and neoplastic skin diseases. It may be particularly useful as a best practice model for smaller departments in order to discuss and/or to confirm diagnoses and also for the management of patients with unusual difficult dermatoses.
Lozzi
G P
GP
Department of Dermatology, University of L'Aquila, L'Aquila, Italy.
Soyer
H P
HP
Massone
C
C
Micantonio
T
T
Kraenke
B
B
Fargnoli
M C
MC
Fink-Puches
R
R
Binder
B
B
Di Stefani
A
A
Hofmann-Wellenhof
R
R
Peris
K
K
D019985:Benchmarking; D003880:Dermatology / Q000592:standards*; D006801:Humans; D012017:Referral and Consultation; D019114:Remote Consultation; D012878:Skin Neoplasms / Q000628:therapy*